Novel motif:106: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif106_KCGCANTC
|novel_motifs_human_sample_pval=11376-118A8_11051;0.114061,11327-117E4_11969;0.0446666,11473-119C6_11054;0.671299,11474-119C7_12067;0.0...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:06, 9 September 2013
name: | motif106_KCGCANTC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006396 | RNA processing | 6.507231e-16 |
GO:0006281 | DNA repair | 2.408997e-15 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 7.536976e-13 |
GO:0006370 | mRNA capping | 1.397424e-11 |
GO:0009452 | RNA capping | 1.811991e-10 |
GO:0032864 | activation of Cdc42 GTPase activity | 3.078338e-9 |
GO:0032790 | ribosome disassembly | 2.070835e-8 |
GO:0034470 | ncRNA processing | 2.766654e-8 |
GO:0045963 | negative regulation of dopamine metabolic process | 5.314833e-8 |
GO:0050668 | positive regulation of homocysteine metabolic process | 5.314833e-8 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.240428e-7 |
GO:0006397 | mRNA processing | 2.346190e-7 |
GO:0031104 | dendrite regeneration | 4.467243e-7 |
GO:0019087 | transformation of host cell by virus | 5.239174e-7 |
GO:0050434 | positive regulation of viral transcription | 5.823391e-7 |
GO:0090162 | establishment of epithelial cell polarity | 7.105871e-7 |
GO:0016071 | mRNA metabolic process | 7.526937e-7 |
GO:0050666 | regulation of homocysteine metabolic process | 8.805431e-7 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.056846e-6 |
GO:0000724 | double-strand break repair via homologous recombination | 1.175005e-6 |
GO:0001510 | RNA methylation | 1.529775e-6 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.794302e-6 |
GO:0000725 | recombinational repair | 1.861105e-6 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.118440e-6 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 2.409552e-6 |
GO:0018872 | arsonoacetate metabolic process | 2.694815e-6 |
GO:0051102 | DNA ligation involved in DNA recombination | 2.694815e-6 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 2.694815e-6 |
GO:0008033 | tRNA processing | 2.977027e-6 |
GO:0070534 | protein K63-linked ubiquitination | 3.079644e-6 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 3.216020e-6 |
GO:0009451 | RNA modification | 4.014860e-6 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 4.108674e-6 |
GO:0006391 | transcription initiation from mitochondrial promoter | 4.949118e-6 |
GO:0006974 | response to DNA damage stimulus | 6.123478e-6 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 6.873519e-6 |
GO:0006354 | transcription elongation, DNA-dependent | 7.651184e-6 |
GO:0061014 | positive regulation of mRNA catabolic process | 7.749167e-6 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 7.886190e-6 |
GO:0035356 | cellular triglyceride homeostasis | 8.491317e-6 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 1.000575e-5 |
GO:0001514 | selenocysteine incorporation | 1.022695e-5 |
GO:0048702 | embryonic neurocranium morphogenesis | 1.052165e-5 |
GO:0046940 | nucleoside monophosphate phosphorylation | 1.131149e-5 |
GO:0033119 | negative regulation of RNA splicing | 1.348097e-5 |
GO:0010912 | positive regulation of isomerase activity | 1.372034e-5 |
GO:0032988 | ribonucleoprotein complex disassembly | 1.655392e-5 |
GO:0006298 | mismatch repair | 1.683263e-5 |
GO:0071044 | histone mRNA catabolic process | 1.719287e-5 |
GO:0021754 | facial nucleus development | 2.053428e-5 |
GO:0040032 | post-embryonic body morphogenesis | 2.264906e-5 |
GO:0061157 | mRNA destabilization | 2.313113e-5 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 2.313113e-5 |
GO:0021903 | rostrocaudal neural tube patterning | 2.482206e-5 |
GO:0006310 | DNA recombination | 2.766694e-5 |
GO:0061090 | positive regulation of sequestering of zinc ion | 2.778101e-5 |
GO:0031119 | tRNA pseudouridine synthesis | 2.778101e-5 |
GO:0033233 | regulation of protein sumoylation | 2.866160e-5 |
GO:0090307 | spindle assembly involved in mitosis | 2.912711e-5 |
GO:0000422 | mitochondrion degradation | 3.405611e-5 |
GO:0006119 | oxidative phosphorylation | 3.415342e-5 |
GO:0031055 | chromatin remodeling at centromere | 3.490967e-5 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 3.498477e-5 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 3.848707e-5 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 3.965458e-5 |
GO:0007051 | spindle organization | 4.166269e-5 |
GO:0021612 | facial nerve structural organization | 4.836700e-5 |
GO:0016482 | cytoplasmic transport | 5.374615e-5 |
GO:0016578 | histone deubiquitination | 5.556550e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 5.743819e-5 |
GO:0046607 | positive regulation of centrosome cycle | 5.807816e-5 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 6.017279e-5 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 6.277170e-5 |
GO:0043486 | histone exchange | 6.340455e-5 |
GO:0070980 | biphenyl catabolic process | 6.793132e-5 |
GO:0052697 | xenobiotic glucuronidation | 6.793132e-5 |
GO:0006789 | bilirubin conjugation | 6.793132e-5 |
GO:0051552 | flavone metabolic process | 6.793132e-5 |
GO:0052696 | flavonoid glucuronidation | 6.793132e-5 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 6.935537e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.954815e-5 |
GO:0006412 | translation | 7.438535e-5 |
GO:0048790 | maintenance of presynaptic active zone structure | 7.996185e-5 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 7.996185e-5 |
GO:0006400 | tRNA modification | 8.032641e-5 |
GO:0043484 | regulation of RNA splicing | 8.641593e-5 |
GO:0006302 | double-strand break repair | 8.998678e-5 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 9.678006e-5 |
GO:0043414 | macromolecule methylation | 9.799772e-5 |
GO:0030262 | apoptotic nuclear change | 9.881172e-5 |
GO:0048486 | parasympathetic nervous system development | 1.144782e-4 |
GO:0060179 | male mating behavior | 1.164735e-4 |
GO:0021571 | rhombomere 5 development | 1.198766e-4 |
GO:0032259 | methylation | 1.258443e-4 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.302672e-4 |
GO:0010172 | embryonic body morphogenesis | 1.317543e-4 |
GO:0000154 | rRNA modification | 1.321758e-4 |
GO:0006054 | N-acetylneuraminate metabolic process | 1.338810e-4 |
GO:0008380 | RNA splicing | 1.357454e-4 |
GO:0006289 | nucleotide-excision repair | 1.367596e-4 |
GO:0008298 | intracellular mRNA localization | 1.479465e-4 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.548918e-4 |
GO:0030683 | evasion by virus of host immune response | 1.645466e-4 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 1.700453e-4 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.886571e-4 |
GO:0051089 | constitutive protein ectodomain proteolysis | 1.936822e-4 |
GO:0085020 | protein K6-linked ubiquitination | 1.955059e-4 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 2.064557e-4 |
GO:0060461 | right lung morphogenesis | 2.096521e-4 |
GO:0090131 | mesenchyme migration | 2.096521e-4 |
GO:0014822 | detection of wounding | 2.096521e-4 |
GO:0060446 | branching involved in open tracheal system development | 2.096521e-4 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 2.096521e-4 |
GO:0048371 | lateral mesodermal cell differentiation | 2.096521e-4 |
GO:0008210 | estrogen metabolic process | 2.106461e-4 |
GO:0006284 | base-excision repair | 2.356742e-4 |
GO:0051225 | spindle assembly | 2.359835e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.489395e-4 |
GO:0031297 | replication fork processing | 2.586730e-4 |
GO:0035519 | protein K29-linked ubiquitination | 2.616728e-4 |
GO:0016567 | protein ubiquitination | 3.113832e-4 |
GO:0018277 | protein deamination | 3.152758e-4 |
GO:0045007 | depurination | 3.152758e-4 |
GO:0042069 | regulation of catecholamine metabolic process | 3.175741e-4 |
GO:0051567 | histone H3-K9 methylation | 3.188084e-4 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 3.222634e-4 |
GO:0044265 | cellular macromolecule catabolic process | 3.351489e-4 |
GO:0061013 | regulation of mRNA catabolic process | 3.359646e-4 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 3.385320e-4 |
GO:0021783 | preganglionic parasympathetic nervous system development | 3.395387e-4 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 3.503358e-4 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 3.626469e-4 |
GO:0090149 | membrane fission involved in mitochondrial fission | 3.700756e-4 |
GO:0070625 | zymogen granule exocytosis | 3.700756e-4 |
GO:0003374 | dynamin polymerization involved in mitochondrial fission | 3.700756e-4 |
GO:0046604 | positive regulation of mitotic centrosome separation | 3.700756e-4 |
GO:0016032 | viral reproduction | 3.722379e-4 |
GO:0000266 | mitochondrial fission | 3.760980e-4 |
GO:0006308 | DNA catabolic process | 3.827315e-4 |
GO:0080009 | mRNA methylation | 3.902241e-4 |
GO:0008049 | male courtship behavior | 3.902241e-4 |
GO:0006285 | base-excision repair, AP site formation | 4.010963e-4 |
GO:0034660 | ncRNA metabolic process | 4.059521e-4 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 4.086134e-4 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 4.094424e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 4.145675e-4 |
GO:0033235 | positive regulation of protein sumoylation | 4.245977e-4 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 4.258550e-4 |
GO:0016072 | rRNA metabolic process | 4.464467e-4 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 4.623389e-4 |
GO:0051645 | Golgi localization | 4.698609e-4 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 4.698609e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 4.719357e-4 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 4.821968e-4 |
GO:0006413 | translational initiation | 4.959945e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 5.001368e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 5.112222e-4 |
GO:0046782 | regulation of viral transcription | 5.198901e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 5.245309e-4 |
GO:0000022 | mitotic spindle elongation | 5.397390e-4 |
GO:0033083 | regulation of immature T cell proliferation | 5.539816e-4 |
GO:0043044 | ATP-dependent chromatin remodeling | 6.292123e-4 |
GO:0051301 | cell division | 6.333480e-4 |
GO:0046605 | regulation of centrosome cycle | 6.360649e-4 |
GO:0006364 | rRNA processing | 6.555149e-4 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 7.194925e-4 |
GO:0021610 | facial nerve morphogenesis | 7.250985e-4 |
GO:0006172 | ADP biosynthetic process | 7.322024e-4 |
GO:0015742 | alpha-ketoglutarate transport | 7.353015e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 7.392196e-4 |
GO:0010467 | gene expression | 7.451951e-4 |
GO:0021569 | rhombomere 3 development | 7.693728e-4 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.787043e-4 |
GO:0000731 | DNA synthesis involved in DNA repair | 7.842565e-4 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 7.842565e-4 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 7.844888e-4 |
GO:0090304 | nucleic acid metabolic process | 8.155910e-4 |
GO:0046939 | nucleotide phosphorylation | 8.276019e-4 |
GO:0046341 | CDP-diacylglycerol metabolic process | 8.463778e-4 |
GO:0042664 | negative regulation of endodermal cell fate specification | 8.770254e-4 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 8.770254e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 8.770254e-4 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 8.770254e-4 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 8.770254e-4 |
GO:0060921 | sinoatrial node cell differentiation | 8.770254e-4 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 8.770254e-4 |
GO:0003210 | cardiac atrium formation | 8.770254e-4 |
GO:0032738 | positive regulation of interleukin-15 production | 8.770254e-4 |
GO:0003236 | sinus venosus morphogenesis | 8.770254e-4 |
GO:0003241 | growth involved in heart morphogenesis | 8.770254e-4 |
GO:0003259 | cardioblast anterior-lateral migration | 8.770254e-4 |
GO:0044314 | protein K27-linked ubiquitination | 9.066143e-4 |
GO:0060741 | prostate gland stromal morphogenesis | 9.109349e-4 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 9.119123e-4 |
GO:0018364 | peptidyl-glutamine methylation | 9.389554e-4 |
GO:0006844 | acyl carnitine transport | 9.389554e-4 |
GO:0006756 | AMP phosphorylation | 9.389554e-4 |
GO:0031167 | rRNA methylation | 9.650346e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 9.873060e-4 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 9.912274e-4 |
GO:0060318 | definitive erythrocyte differentiation | 1.013457e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.020316e-3 |
GO:0060876 | semicircular canal formation | 1.091479e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 1.125763e-3 |
GO:0060458 | right lung development | 1.138040e-3 |
GO:0006927 | transformed cell apoptosis | 1.192731e-3 |
GO:0035305 | negative regulation of dephosphorylation | 1.208485e-3 |
GO:0010498 | proteasomal protein catabolic process | 1.222363e-3 |
GO:0070079 | histone H4-R3 demethylation | 1.265351e-3 |
GO:0070078 | histone H3-R2 demethylation | 1.265351e-3 |
GO:0015680 | intracellular copper ion transport | 1.265351e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.265351e-3 |
GO:0000959 | mitochondrial RNA metabolic process | 1.308116e-3 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 1.318961e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.318961e-3 |
GO:0051984 | positive regulation of chromosome segregation | 1.318961e-3 |
GO:0033342 | negative regulation of collagen binding | 1.318961e-3 |
GO:0006311 | meiotic gene conversion | 1.318961e-3 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 1.336267e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.375096e-3 |
GO:0034699 | response to luteinizing hormone stimulus | 1.375096e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.381614e-3 |
GO:0015074 | DNA integration | 1.424292e-3 |
GO:0072321 | chaperone-mediated protein transport | 1.455405e-3 |
GO:0034968 | histone lysine methylation | 1.468600e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.513970e-3 |
GO:0006924 | activation-induced cell death of T cells | 1.523726e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 1.528094e-3 |
GO:0048524 | positive regulation of viral reproduction | 1.529176e-3 |
GO:0046164 | alcohol catabolic process | 1.547846e-3 |
GO:0006449 | regulation of translational termination | 1.555171e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 1.560820e-3 |
GO:0060029 | convergent extension involved in organogenesis | 1.576684e-3 |
GO:0006406 | mRNA export from nucleus | 1.584318e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.585781e-3 |
GO:0021561 | facial nerve development | 1.585781e-3 |
GO:0021570 | rhombomere 4 development | 1.595880e-3 |
GO:0048102 | autophagic cell death | 1.636784e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.641889e-3 |
GO:0019047 | provirus integration | 1.662464e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.699202e-3 |
GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 1.700538e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.755321e-3 |
GO:0006405 | RNA export from nucleus | 1.809327e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 1.839698e-3 |
GO:0035646 | endosome to melanosome transport | 1.906966e-3 |
GO:0032581 | ER-dependent peroxisome organization | 1.906966e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 1.972626e-3 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 1.987149e-3 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.000763e-3 |
GO:0051351 | positive regulation of ligase activity | 2.027100e-3 |
GO:0006390 | transcription from mitochondrial promoter | 2.027656e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 2.032701e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.056295e-3 |
GO:0006108 | malate metabolic process | 2.085162e-3 |
GO:0046416 | D-amino acid metabolic process | 2.094444e-3 |
GO:0006173 | dADP biosynthetic process | 2.094444e-3 |
GO:0051083 | 'de novo' cotranslational protein folding | 2.100690e-3 |
GO:0006548 | histidine catabolic process | 2.108883e-3 |
GO:0021599 | abducens nerve formation | 2.205514e-3 |
GO:0007634 | optokinetic behavior | 2.205514e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 2.205869e-3 |
GO:0001522 | pseudouridine synthesis | 2.268564e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 2.302234e-3 |
GO:0032446 | protein modification by small protein conjugation | 2.325097e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 2.383867e-3 |
GO:0060623 | regulation of chromosome condensation | 2.383867e-3 |
GO:0071283 | cellular response to iron(III) ion | 2.383867e-3 |
GO:0046680 | response to DDT | 2.383867e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 2.383867e-3 |
GO:0046380 | N-acetylneuraminate biosynthetic process | 2.383867e-3 |
GO:0016078 | tRNA catabolic process | 2.383867e-3 |
GO:0001682 | tRNA 5'-leader removal | 2.383867e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 2.383867e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 2.454081e-3 |
GO:0015728 | mevalonate transport | 2.586136e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 2.608729e-3 |
GO:0042373 | vitamin K metabolic process | 2.641856e-3 |
GO:0002115 | store-operated calcium entry | 2.641856e-3 |
GO:0034389 | lipid particle organization | 2.641856e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.649564e-3 |
GO:0000236 | mitotic prometaphase | 2.737197e-3 |
GO:0006266 | DNA ligation | 2.785019e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 2.788963e-3 |
GO:0006353 | transcription termination, DNA-dependent | 2.802650e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 2.816018e-3 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 2.862643e-3 |
GO:0042420 | dopamine catabolic process | 2.885138e-3 |
GO:0033578 | protein glycosylation in Golgi | 2.935042e-3 |
GO:0015827 | tryptophan transport | 2.935042e-3 |
GO:0042053 | regulation of dopamine metabolic process | 2.968341e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 2.968824e-3 |
GO:0050686 | negative regulation of mRNA processing | 2.997684e-3 |
GO:0006730 | one-carbon metabolic process | 3.042484e-3 |
GO:0030967 | ER-nuclear sterol response pathway | 3.179577e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.217646e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 3.232165e-3 |
GO:0006259 | DNA metabolic process | 3.278000e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 3.329900e-3 |
GO:0006376 | mRNA splice site selection | 3.336387e-3 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 3.443857e-3 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 3.443857e-3 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 3.443857e-3 |
GO:0009088 | threonine biosynthetic process | 3.443857e-3 |
GO:0007057 | spindle assembly involved in female meiosis I | 3.443857e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 3.443857e-3 |
GO:0006529 | asparagine biosynthetic process | 3.476233e-3 |
GO:0050975 | sensory perception of touch | 3.493257e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 3.512318e-3 |
GO:0021993 | initiation of neural tube closure | 3.559286e-3 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 3.637821e-3 |
GO:0016559 | peroxisome fission | 3.678485e-3 |
GO:0014028 | notochord formation | 3.678485e-3 |
GO:0021506 | anterior neuropore closure | 3.741342e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 3.746358e-3 |
GO:0002011 | morphogenesis of an epithelial sheet | 3.885642e-3 |
GO:0006547 | histidine metabolic process | 3.900350e-3 |
GO:0048370 | lateral mesoderm formation | 3.939995e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 3.983207e-3 |
GO:0031123 | RNA 3'-end processing | 4.004450e-3 |
GO:0042254 | ribosome biogenesis | 4.032206e-3 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 4.100980e-3 |
GO:0018205 | peptidyl-lysine modification | 4.116836e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 4.135496e-3 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 4.185424e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 4.240812e-3 |
GO:0006538 | glutamate catabolic process | 4.257007e-3 |
GO:0006098 | pentose-phosphate shunt | 4.303467e-3 |
GO:0048561 | establishment of organ orientation | 4.398459e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 4.398459e-3 |
GO:0009107 | lipoate biosynthetic process | 4.398459e-3 |
GO:0014904 | myotube cell development | 4.398459e-3 |
GO:0001830 | trophectodermal cell fate commitment | 4.398459e-3 |
GO:0019321 | pentose metabolic process | 4.406065e-3 |
GO:0032288 | myelin assembly | 4.521504e-3 |
GO:0032467 | positive regulation of cytokinesis | 4.524956e-3 |
GO:0021546 | rhombomere development | 4.602047e-3 |
GO:0000279 | M phase | 4.654803e-3 |
GO:0031427 | response to methotrexate | 4.667959e-3 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 4.667959e-3 |
GO:0006110 | regulation of glycolysis | 4.819222e-3 |
GO:0019941 | modification-dependent protein catabolic process | 4.835603e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 4.837361e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 4.914657e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 4.968149e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 5.042058e-3 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 5.042058e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 5.042058e-3 |
GO:0019358 | nicotinate nucleotide salvage | 5.042058e-3 |
GO:0006781 | succinyl-CoA pathway | 5.042058e-3 |
GO:0006713 | glucocorticoid catabolic process | 5.042058e-3 |
GO:0051081 | nuclear envelope disassembly | 5.405387e-3 |
GO:0044257 | cellular protein catabolic process | 5.539544e-3 |
GO:0046599 | regulation of centriole replication | 5.557134e-3 |
GO:0033182 | regulation of histone ubiquitination | 5.703197e-3 |
GO:0090007 | regulation of mitotic anaphase | 5.703197e-3 |
GO:0006051 | N-acetylmannosamine metabolic process | 5.703197e-3 |
GO:0050935 | iridophore differentiation | 5.708418e-3 |
GO:0048937 | lateral line nerve glial cell development | 5.708418e-3 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 5.794472e-3 |
GO:0070979 | protein K11-linked ubiquitination | 5.845279e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 5.946158e-3 |
GO:0003326 | pancreatic A cell fate commitment | 5.946158e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 5.946158e-3 |
GO:0042941 | D-alanine transport | 5.986508e-3 |
GO:0006975 | DNA damage induced protein phosphorylation | 5.991269e-3 |
GO:0001507 | acetylcholine catabolic process in synaptic cleft | 6.085517e-3 |
GO:0021997 | neural plate axis specification | 6.197813e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 6.243133e-3 |
GO:0006301 | postreplication repair | 6.319372e-3 |
GO:0048285 | organelle fission | 6.432751e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.476886e-3 |
GO:0045046 | protein import into peroxisome membrane | 6.545017e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 6.580961e-3 |
GO:0001842 | neural fold formation | 6.613402e-3 |
GO:0002086 | diaphragm contraction | 6.613402e-3 |
GO:0030953 | astral microtubule organization | 6.629561e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 6.658419e-3 |
GO:0009648 | photoperiodism | 6.658419e-3 |
GO:0006260 | DNA replication | 6.830305e-3 |
GO:0003016 | respiratory system process | 6.870129e-3 |
GO:0010939 | regulation of necrotic cell death | 6.927837e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 7.128620e-3 |
GO:0070873 | regulation of glycogen metabolic process | 7.132369e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 7.264310e-3 |
GO:0018022 | peptidyl-lysine methylation | 7.271147e-3 |
GO:0021548 | pons development | 7.320733e-3 |
GO:0048631 | regulation of skeletal muscle tissue growth | 7.482893e-3 |
GO:0021660 | rhombomere 3 formation | 7.526543e-3 |
GO:0021666 | rhombomere 5 formation | 7.526543e-3 |
GO:0015866 | ADP transport | 7.526543e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 7.592156e-3 |
GO:0045351 | type I interferon biosynthetic process | 7.698349e-3 |
GO:0071455 | cellular response to hyperoxia | 7.731008e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 7.731008e-3 |
GO:0001840 | neural plate development | 7.822965e-3 |
GO:0007379 | segment specification | 7.825727e-3 |
GO:0051457 | maintenance of protein location in nucleus | 7.889435e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 8.211325e-3 |
GO:0009804 | coumarin metabolic process | 8.211325e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 8.211325e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 8.212042e-3 |
GO:0071242 | cellular response to ammonium ion | 8.212042e-3 |
GO:0006233 | dTDP biosynthetic process | 8.212042e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 8.311320e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 8.468440e-3 |
GO:0045773 | positive regulation of axon extension | 8.482946e-3 |
GO:0015853 | adenine transport | 8.522203e-3 |
GO:0043570 | maintenance of DNA repeat elements | 8.556766e-3 |
GO:0042424 | catecholamine catabolic process | 8.572690e-3 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 8.812842e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 8.834795e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 9.145162e-3 |
GO:0050973 | detection of mechanical stimulus involved in equilibrioception | 9.145162e-3 |
GO:0070370 | cellular heat acclimation | 9.145162e-3 |
GO:0048291 | isotype switching to IgG isotypes | 9.145162e-3 |
GO:0002368 | B cell cytokine production | 9.145162e-3 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 9.145162e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 9.145162e-3 |
GO:0009436 | glyoxylate catabolic process | 9.145162e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 9.164810e-3 |
GO:0002331 | pre-B cell allelic exclusion | 9.654156e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 9.654156e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 9.696071e-3 |
GO:0060872 | semicircular canal development | 9.765264e-3 |
GO:0008334 | histone mRNA metabolic process | 1.032906e-2 |
GO:0043931 | ossification involved in bone maturation | 1.036948e-2 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 1.036948e-2 |
GO:0070366 | regulation of hepatocyte differentiation | 1.048405e-2 |
GO:0010070 | zygote asymmetric cell division | 1.048405e-2 |
GO:0021586 | pons maturation | 1.048610e-2 |
GO:0016574 | histone ubiquitination | 1.055038e-2 |
GO:0010225 | response to UV-C | 1.063722e-2 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 1.063722e-2 |
GO:0050689 | negative regulation of defense response to virus by host | 1.083641e-2 |
GO:0006313 | transposition, DNA-mediated | 1.083641e-2 |
GO:0048075 | positive regulation of eye pigmentation | 1.083641e-2 |
GO:0051256 | spindle midzone assembly involved in mitosis | 1.085382e-2 |
GO:0035308 | negative regulation of protein dephosphorylation | 1.093544e-2 |
GO:0045454 | cell redox homeostasis | 1.112535e-2 |
GO:0060606 | tube closure | 1.117525e-2 |
GO:0005981 | regulation of glycogen catabolic process | 1.118242e-2 |
GO:0001738 | morphogenesis of a polarized epithelium | 1.131982e-2 |
GO:0043543 | protein acylation | 1.153459e-2 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 1.164463e-2 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 1.206743e-2 |
GO:0045988 | negative regulation of striated muscle contraction | 1.208821e-2 |
GO:0010940 | positive regulation of necrotic cell death | 1.234359e-2 |
GO:0022411 | cellular component disassembly | 1.240684e-2 |
GO:0048752 | semicircular canal morphogenesis | 1.241379e-2 |
GO:0000729 | DNA double-strand break processing | 1.261926e-2 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.267017e-2 |
GO:0019088 | immortalization of host cell by virus | 1.297810e-2 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 1.297810e-2 |
GO:0006741 | NADP biosynthetic process | 1.297810e-2 |
GO:0006231 | dTMP biosynthetic process | 1.297810e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 1.300540e-2 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.308092e-2 |
GO:0090085 | regulation of protein deubiquitination | 1.308678e-2 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 1.308678e-2 |
GO:0032025 | response to cobalt ion | 1.372709e-2 |
GO:0032148 | activation of protein kinase B activity | 1.389966e-2 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 1.391810e-2 |
GO:0043105 | negative regulation of GTP cyclohydrolase I activity | 1.391810e-2 |
GO:0071506 | cellular response to mycophenolic acid | 1.393304e-2 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.393304e-2 |
GO:0006473 | protein acetylation | 1.395727e-2 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.418058e-2 |
GO:0070537 | histone H2A K63-linked deubiquitination | 1.418425e-2 |
GO:0030719 | P granule organization | 1.418425e-2 |
GO:0030488 | tRNA methylation | 1.418425e-2 |
GO:0010591 | regulation of lamellipodium assembly | 1.429526e-2 |
GO:0016180 | snRNA processing | 1.438550e-2 |
GO:0007052 | mitotic spindle organization | 1.445637e-2 |
GO:0007007 | inner mitochondrial membrane organization | 1.449555e-2 |
GO:0071845 | cellular component disassembly at cellular level | 1.452574e-2 |
GO:0030163 | protein catabolic process | 1.455588e-2 |
GO:0006740 | NADPH regeneration | 1.464722e-2 |
GO:0009057 | macromolecule catabolic process | 1.472875e-2 |
GO:2000627 | positive regulation of miRNA catabolic process | 1.473124e-2 |
GO:0072661 | protein targeting to plasma membrane | 1.473124e-2 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 1.473124e-2 |
GO:0000964 | mitochondrial RNA 5'-end processing | 1.473124e-2 |
GO:0045039 | protein import into mitochondrial inner membrane | 1.479135e-2 |
GO:0007549 | dosage compensation | 1.479135e-2 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 1.482073e-2 |
GO:0097037 | heme export | 1.493572e-2 |
GO:0016095 | polyprenol catabolic process | 1.493572e-2 |
GO:0070407 | oxidation-dependent protein catabolic process | 1.493572e-2 |
GO:0060209 | estrus | 1.493572e-2 |
GO:0046168 | glycerol-3-phosphate catabolic process | 1.493572e-2 |
GO:0045910 | negative regulation of DNA recombination | 1.496396e-2 |
GO:0006479 | protein methylation | 1.519334e-2 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 1.531415e-2 |
GO:0006925 | inflammatory cell apoptosis | 1.531415e-2 |
GO:0001843 | neural tube closure | 1.537264e-2 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.571060e-2 |
GO:0006268 | DNA unwinding involved in replication | 1.596080e-2 |
GO:0006014 | D-ribose metabolic process | 1.599651e-2 |
GO:0044154 | histone H3-K14 acetylation | 1.620575e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0000279 | M phase | 5.175640e-18 |
GO:0022403 | cell cycle phase | 6.006320e-14 |
GO:0006396 | RNA processing | 1.651736e-12 |
GO:0034660 | ncRNA metabolic process | 2.340635e-12 |
GO:0007067 | mitosis | 2.411433e-11 |
GO:0000087 | M phase of mitotic cell cycle | 3.169572e-11 |
GO:0007049 | cell cycle | 3.804385e-11 |
GO:0048285 | organelle fission | 6.107657e-11 |
GO:0034470 | ncRNA processing | 1.581911e-10 |
GO:0044260 | cellular macromolecule metabolic process | 2.737571e-10 |
GO:0032446 | protein modification by small protein conjugation | 3.243280e-10 |
GO:0006474 | N-terminal protein amino acid acetylation | 3.380637e-10 |
GO:0022402 | cell cycle process | 4.405413e-10 |
GO:0045116 | protein neddylation | 4.577588e-10 |
GO:0006406 | mRNA export from nucleus | 6.202904e-10 |
GO:0071843 | cellular component biogenesis at cellular level | 7.181907e-10 |
GO:0006405 | RNA export from nucleus | 7.911352e-10 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 9.279311e-10 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.035716e-9 |
GO:0090304 | nucleic acid metabolic process | 2.355902e-9 |
GO:0016567 | protein ubiquitination | 7.708246e-9 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 8.074746e-9 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.074482e-8 |
GO:0031365 | N-terminal protein amino acid modification | 1.363996e-8 |
GO:0010896 | regulation of triglyceride catabolic process | 1.516177e-8 |
GO:0051301 | cell division | 1.903222e-8 |
GO:0006281 | DNA repair | 2.622703e-8 |
GO:0048368 | lateral mesoderm development | 2.990508e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 3.099602e-8 |
GO:0032467 | positive regulation of cytokinesis | 4.015033e-8 |
GO:0051168 | nuclear export | 5.462811e-8 |
GO:0000278 | mitotic cell cycle | 5.467557e-8 |
GO:0008380 | RNA splicing | 5.559596e-8 |
GO:0006364 | rRNA processing | 1.005487e-7 |
GO:0071168 | protein localization to chromatin | 1.010637e-7 |
GO:0007051 | spindle organization | 1.019481e-7 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.293804e-7 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.806422e-7 |
GO:0042273 | ribosomal large subunit biogenesis | 1.875765e-7 |
GO:0030163 | protein catabolic process | 2.740612e-7 |
GO:0071169 | establishment of protein localization to chromatin | 3.239267e-7 |
GO:0010467 | gene expression | 4.206002e-7 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 4.533279e-7 |
GO:0051225 | spindle assembly | 6.190984e-7 |
GO:0043632 | modification-dependent macromolecule catabolic process | 6.734173e-7 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.132775e-7 |
GO:0051276 | chromosome organization | 7.247728e-7 |
GO:0016072 | rRNA metabolic process | 8.440328e-7 |
GO:0019941 | modification-dependent protein catabolic process | 9.579181e-7 |
GO:0034587 | piRNA metabolic process | 1.413053e-6 |
GO:0071173 | spindle assembly checkpoint | 1.580068e-6 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 1.869308e-6 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.174772e-6 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.323278e-6 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.323278e-6 |
GO:0031577 | spindle checkpoint | 2.324707e-6 |
GO:0006105 | succinate metabolic process | 2.352568e-6 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 2.598566e-6 |
GO:0031848 | protection from non-homologous end joining at telomere | 2.853847e-6 |
GO:0071826 | ribonucleoprotein complex subunit organization | 2.974232e-6 |
GO:0006974 | response to DNA damage stimulus | 2.996447e-6 |
GO:0010891 | negative regulation of sequestering of triglyceride | 3.208324e-6 |
GO:0034502 | protein localization to chromosome | 3.319145e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.409292e-6 |
GO:0060458 | right lung development | 3.511389e-6 |
GO:0006259 | DNA metabolic process | 3.674694e-6 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.802286e-6 |
GO:0006540 | glutamate decarboxylation to succinate | 3.802286e-6 |
GO:0022618 | ribonucleoprotein complex assembly | 4.084458e-6 |
GO:0051028 | mRNA transport | 4.922810e-6 |
GO:0042254 | ribosome biogenesis | 5.820473e-6 |
GO:0051321 | meiotic cell cycle | 5.830302e-6 |
GO:0090231 | regulation of spindle checkpoint | 6.308146e-6 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 6.972187e-6 |
GO:0030263 | apoptotic chromosome condensation | 7.126478e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 8.040503e-6 |
GO:0030719 | P granule organization | 8.730732e-6 |
GO:0035520 | monoubiquitinated protein deubiquitination | 9.468788e-6 |
GO:0018206 | peptidyl-methionine modification | 9.468788e-6 |
GO:0009057 | macromolecule catabolic process | 9.826302e-6 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.202651e-5 |
GO:0006412 | translation | 1.317512e-5 |
GO:0030262 | apoptotic nuclear change | 1.369190e-5 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.376685e-5 |
GO:0006397 | mRNA processing | 1.577574e-5 |
GO:0010501 | RNA secondary structure unwinding | 1.785930e-5 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.852388e-5 |
GO:0007126 | meiosis | 2.070931e-5 |
GO:0016071 | mRNA metabolic process | 2.106599e-5 |
GO:0006538 | glutamate catabolic process | 2.293263e-5 |
GO:0006430 | lysyl-tRNA aminoacylation | 2.316030e-5 |
GO:0046452 | dihydrofolate metabolic process | 2.316030e-5 |
GO:0048239 | negative regulation of DNA recombination at telomere | 2.316030e-5 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 2.316030e-5 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 2.364594e-5 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 2.364594e-5 |
GO:0010312 | detoxification of zinc ion | 2.364594e-5 |
GO:0034442 | regulation of lipoprotein oxidation | 2.378171e-5 |
GO:0000245 | spliceosome assembly | 2.449180e-5 |
GO:0009262 | deoxyribonucleotide metabolic process | 2.662193e-5 |
GO:0044257 | cellular protein catabolic process | 2.691376e-5 |
GO:0050823 | peptide antigen stabilization | 2.834330e-5 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.834330e-5 |
GO:0050658 | RNA transport | 2.866830e-5 |
GO:0033523 | histone H2B ubiquitination | 2.980351e-5 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 3.039079e-5 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 3.039079e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 3.423706e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 3.423706e-5 |
GO:0006325 | chromatin organization | 3.457487e-5 |
GO:0016070 | RNA metabolic process | 3.604845e-5 |
GO:0035092 | sperm chromatin condensation | 3.782699e-5 |
GO:0007028 | cytoplasm organization | 3.881932e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 3.909920e-5 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 4.325789e-5 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.425395e-5 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 4.494776e-5 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 4.494776e-5 |
GO:0006403 | RNA localization | 4.948487e-5 |
GO:0032922 | circadian regulation of gene expression | 4.988908e-5 |
GO:0010898 | positive regulation of triglyceride catabolic process | 5.315921e-5 |
GO:0006391 | transcription initiation from mitochondrial promoter | 5.923590e-5 |
GO:0006807 | nitrogen compound metabolic process | 6.166126e-5 |
GO:0001880 | Mullerian duct regression | 6.245231e-5 |
GO:0006473 | protein acetylation | 6.417165e-5 |
GO:0006306 | DNA methylation | 6.644911e-5 |
GO:0010878 | cholesterol storage | 6.914715e-5 |
GO:0016568 | chromatin modification | 7.088201e-5 |
GO:0030300 | regulation of intestinal cholesterol absorption | 7.508108e-5 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 8.042674e-5 |
GO:0032465 | regulation of cytokinesis | 8.610140e-5 |
GO:0044265 | cellular macromolecule catabolic process | 9.132566e-5 |
GO:0010889 | regulation of sequestering of triglyceride | 9.840043e-5 |
GO:0000460 | maturation of 5.8S rRNA | 9.981913e-5 |
GO:0090224 | regulation of spindle organization | 1.031739e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.032072e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.091764e-4 |
GO:0010661 | positive regulation of muscle cell apoptosis | 1.091764e-4 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.123564e-4 |
GO:0007059 | chromosome segregation | 1.182126e-4 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 1.191050e-4 |
GO:0051103 | DNA ligation involved in DNA repair | 1.243078e-4 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 1.252663e-4 |
GO:2000682 | positive regulation of rubidium ion transport | 1.252663e-4 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.252663e-4 |
GO:0035826 | rubidium ion transport | 1.252663e-4 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 1.371415e-4 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.375965e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.404827e-4 |
GO:0061084 | negative regulation of protein refolding | 1.411194e-4 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.489109e-4 |
GO:0046607 | positive regulation of centrosome cycle | 1.489109e-4 |
GO:0043148 | mitotic spindle stabilization | 1.489109e-4 |
GO:0006713 | glucocorticoid catabolic process | 1.489109e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.489109e-4 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.622464e-4 |
GO:0042851 | L-alanine metabolic process | 1.671031e-4 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 1.671031e-4 |
GO:0015876 | acetyl-CoA transport | 1.671031e-4 |
GO:0033169 | histone H3-K9 demethylation | 1.700914e-4 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.713607e-4 |
GO:0007052 | mitotic spindle organization | 1.725940e-4 |
GO:0006982 | response to lipid hydroperoxide | 1.754155e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 1.754155e-4 |
GO:0043543 | protein acylation | 1.873365e-4 |
GO:0010872 | regulation of cholesterol esterification | 1.928377e-4 |
GO:0071476 | cellular hypotonic response | 1.963917e-4 |
GO:0006663 | platelet activating factor biosynthetic process | 1.963917e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 2.037840e-4 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 2.133568e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.156643e-4 |
GO:0051973 | positive regulation of telomerase activity | 2.162898e-4 |
GO:0071267 | L-methionine salvage | 2.162898e-4 |
GO:0035093 | spermatogenesis, exchange of chromosomal proteins | 2.162898e-4 |
GO:0051135 | positive regulation of NK T cell activation | 2.215679e-4 |
GO:0006545 | glycine biosynthetic process | 2.225002e-4 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.243098e-4 |
GO:0042559 | pteridine-containing compound biosynthetic process | 2.334035e-4 |
GO:0007256 | activation of JNKK activity | 2.360516e-4 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 2.394950e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 2.518346e-4 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 2.653789e-4 |
GO:0065005 | protein-lipid complex assembly | 2.686174e-4 |
GO:0006370 | mRNA capping | 2.687521e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.901843e-4 |
GO:0051568 | histone H3-K4 methylation | 3.012027e-4 |
GO:0061088 | regulation of sequestering of zinc ion | 3.223409e-4 |
GO:2000062 | negative regulation of ureter smooth muscle cell differentiation | 3.449717e-4 |
GO:2000063 | positive regulation of ureter smooth muscle cell differentiation | 3.449717e-4 |
GO:0080125 | multicellular structure septum development | 3.449717e-4 |
GO:2000357 | negative regulation of kidney smooth muscle cell differentiation | 3.449717e-4 |
GO:2000358 | positive regulation of kidney smooth muscle cell differentiation | 3.449717e-4 |
GO:0046534 | positive regulation of photoreceptor cell differentiation | 3.449717e-4 |
GO:0007502 | digestive tract mesoderm development | 3.449717e-4 |
GO:0060783 | mesenchymal smoothened signaling pathway involved in prostate gland development | 3.449717e-4 |
GO:0014858 | positive regulation of skeletal muscle cell proliferation | 3.449717e-4 |
GO:0060782 | regulation of mesenchymal cell proliferation involved in prostate gland development | 3.449717e-4 |
GO:0008033 | tRNA processing | 3.468138e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 3.597063e-4 |
GO:0000959 | mitochondrial RNA metabolic process | 3.647395e-4 |
GO:0048050 | post-embryonic eye morphogenesis | 3.729828e-4 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 3.735858e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 3.857848e-4 |
GO:0046605 | regulation of centrosome cycle | 3.905052e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 3.953565e-4 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 3.953565e-4 |
GO:0032383 | regulation of intracellular cholesterol transport | 3.953565e-4 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 3.953565e-4 |
GO:0048808 | male genitalia morphogenesis | 4.056197e-4 |
GO:0046112 | nucleobase biosynthetic process | 4.645585e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 4.757753e-4 |
GO:0045351 | type I interferon biosynthetic process | 4.829030e-4 |
GO:0000209 | protein polyubiquitination | 4.920773e-4 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 4.991296e-4 |
GO:0048352 | paraxial mesoderm structural organization | 5.199102e-4 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 5.199102e-4 |
GO:0008208 | C21-steroid hormone catabolic process | 5.199102e-4 |
GO:0021998 | neural plate mediolateral regionalization | 5.199102e-4 |
GO:0009299 | mRNA transcription | 5.280570e-4 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 5.280570e-4 |
GO:0043170 | macromolecule metabolic process | 5.288999e-4 |
GO:0000002 | mitochondrial genome maintenance | 5.646297e-4 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 5.779476e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 5.849224e-4 |
GO:0045056 | transcytosis | 5.973964e-4 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 6.014806e-4 |
GO:0030202 | heparin metabolic process | 6.014806e-4 |
GO:0006260 | DNA replication | 6.113872e-4 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 6.192028e-4 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 6.192028e-4 |
GO:0032859 | activation of Ral GTPase activity | 6.214775e-4 |
GO:0010921 | regulation of phosphatase activity | 6.616276e-4 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 6.654925e-4 |
GO:0006399 | tRNA metabolic process | 6.783509e-4 |
GO:0045948 | positive regulation of translational initiation | 7.085465e-4 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 7.085465e-4 |
GO:0016068 | type I hypersensitivity | 7.435968e-4 |
GO:0008334 | histone mRNA metabolic process | 8.008228e-4 |
GO:0070936 | protein K48-linked ubiquitination | 8.341373e-4 |
GO:0044058 | regulation of digestive system process | 8.702805e-4 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 8.753311e-4 |
GO:0048291 | isotype switching to IgG isotypes | 8.864456e-4 |
GO:0002368 | B cell cytokine production | 8.864456e-4 |
GO:0000226 | microtubule cytoskeleton organization | 9.191301e-4 |
GO:0035566 | regulation of metanephros size | 9.261041e-4 |
GO:0009064 | glutamine family amino acid metabolic process | 9.360406e-4 |
GO:0031119 | tRNA pseudouridine synthesis | 9.510322e-4 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 9.510322e-4 |
GO:0044237 | cellular metabolic process | 9.716786e-4 |
GO:0060621 | negative regulation of cholesterol import | 9.909382e-4 |
GO:0009086 | methionine biosynthetic process | 1.036730e-3 |
GO:2000015 | regulation of determination of dorsal identity | 1.037982e-3 |
GO:0010888 | negative regulation of lipid storage | 1.042592e-3 |
GO:0070328 | triglyceride homeostasis | 1.061465e-3 |
GO:0055090 | acylglycerol homeostasis | 1.066690e-3 |
GO:0060236 | regulation of mitotic spindle organization | 1.113110e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.113110e-3 |
GO:0016539 | intein-mediated protein splicing | 1.113110e-3 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.113110e-3 |
GO:0072172 | mesonephric tubule formation | 1.175454e-3 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 1.237879e-3 |
GO:0072075 | metanephric mesenchyme development | 1.240269e-3 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 1.262963e-3 |
GO:0043414 | macromolecule methylation | 1.277222e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 1.288280e-3 |
GO:0032799 | low-density lipoprotein receptor particle metabolic process | 1.288280e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 1.288280e-3 |
GO:0051972 | regulation of telomerase activity | 1.296734e-3 |
GO:0034968 | histone lysine methylation | 1.300716e-3 |
GO:0051095 | regulation of helicase activity | 1.302633e-3 |
GO:0070076 | histone lysine demethylation | 1.313403e-3 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 1.338283e-3 |
GO:0070198 | protein localization to chromosome, telomeric region | 1.339437e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.410963e-3 |
GO:0006555 | methionine metabolic process | 1.411791e-3 |
GO:0006493 | protein O-linked glycosylation | 1.417669e-3 |
GO:0043691 | reverse cholesterol transport | 1.443286e-3 |
GO:0048255 | mRNA stabilization | 1.474413e-3 |
GO:0006284 | base-excision repair | 1.478379e-3 |
GO:0043484 | regulation of RNA splicing | 1.504826e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 1.525028e-3 |
GO:0090193 | positive regulation of glomerulus development | 1.534253e-3 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.534253e-3 |
GO:0009067 | aspartate family amino acid biosynthetic process | 1.583781e-3 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1.635649e-3 |
GO:0070370 | cellular heat acclimation | 1.655504e-3 |
GO:0071279 | cellular response to cobalt ion | 1.655504e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.655504e-3 |
GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.655504e-3 |
GO:0035356 | cellular triglyceride homeostasis | 1.655504e-3 |
GO:0051096 | positive regulation of helicase activity | 1.709674e-3 |
GO:0043687 | post-translational protein modification | 1.876866e-3 |
GO:0006266 | DNA ligation | 1.876866e-3 |
GO:0032025 | response to cobalt ion | 1.883446e-3 |
GO:0002227 | innate immune response in mucosa | 1.883446e-3 |
GO:0050434 | positive regulation of viral transcription | 1.925958e-3 |
GO:0015724 | formate transport | 1.930944e-3 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 2.002624e-3 |
GO:0006390 | transcription from mitochondrial promoter | 2.036067e-3 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 2.123221e-3 |
GO:0035269 | protein O-linked mannosylation | 2.134517e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 2.159962e-3 |
GO:0031167 | rRNA methylation | 2.159962e-3 |
GO:0006308 | DNA catabolic process | 2.226217e-3 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 2.235625e-3 |
GO:0045837 | negative regulation of membrane potential | 2.237177e-3 |
GO:0060447 | bud outgrowth involved in lung branching | 2.238611e-3 |
GO:0032119 | sequestering of zinc ion | 2.243109e-3 |
GO:0060620 | regulation of cholesterol import | 2.305330e-3 |
GO:0090083 | regulation of inclusion body assembly | 2.305330e-3 |
GO:0010887 | negative regulation of cholesterol storage | 2.305330e-3 |
GO:0008629 | induction of apoptosis by intracellular signals | 2.378316e-3 |
GO:0006376 | mRNA splice site selection | 2.379133e-3 |
GO:0042667 | auditory receptor cell fate specification | 2.408804e-3 |
GO:0045609 | positive regulation of auditory receptor cell differentiation | 2.408804e-3 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 2.408804e-3 |
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 2.408804e-3 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 2.410055e-3 |
GO:0070534 | protein K63-linked ubiquitination | 2.428906e-3 |
GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter | 2.449198e-3 |
GO:0006264 | mitochondrial DNA replication | 2.513753e-3 |
GO:0071845 | cellular component disassembly at cellular level | 2.538856e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 2.631456e-3 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 2.631456e-3 |
GO:0043305 | negative regulation of mast cell degranulation | 2.631456e-3 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 2.631456e-3 |
GO:0060463 | lung lobe morphogenesis | 2.673220e-3 |
GO:0032606 | type I interferon production | 2.677036e-3 |
GO:0051318 | G1 phase | 2.725303e-3 |
GO:0071044 | histone mRNA catabolic process | 2.789107e-3 |
GO:0090307 | spindle assembly involved in mitosis | 2.849342e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.869296e-3 |
GO:0019348 | dolichol metabolic process | 2.869296e-3 |
GO:0014904 | myotube cell development | 2.920735e-3 |
GO:0044267 | cellular protein metabolic process | 2.949269e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 2.981742e-3 |
GO:0000710 | meiotic mismatch repair | 3.079370e-3 |
GO:0009452 | RNA capping | 3.079370e-3 |
GO:0031508 | centromeric heterochromatin formation | 3.138641e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 3.341354e-3 |
GO:0042089 | cytokine biosynthetic process | 3.358514e-3 |
GO:0022411 | cellular component disassembly | 3.402279e-3 |
GO:0072184 | renal vesicle progenitor cell differentiation | 3.486172e-3 |
GO:0072169 | specification of posterior mesonephric tubule identity | 3.486172e-3 |
GO:0072208 | metanephric smooth muscle tissue development | 3.486172e-3 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 3.486172e-3 |
GO:0072168 | specification of anterior mesonephric tubule identity | 3.486172e-3 |
GO:0090131 | mesenchyme migration | 3.486172e-3 |
GO:0072259 | metanephric interstitial cell development | 3.486172e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 3.486172e-3 |
GO:0048371 | lateral mesodermal cell differentiation | 3.486172e-3 |
GO:0035674 | tricarboxylic acid transmembrane transport | 3.486172e-3 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 3.486172e-3 |
GO:0060446 | branching involved in open tracheal system development | 3.486172e-3 |
GO:0060461 | right lung morphogenesis | 3.486172e-3 |
GO:0014822 | detection of wounding | 3.486172e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 3.525126e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 3.525126e-3 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 3.587303e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.587303e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 3.594408e-3 |
GO:0016574 | histone ubiquitination | 3.643530e-3 |
GO:0090208 | positive regulation of triglyceride metabolic process | 3.690119e-3 |
GO:0071470 | cellular response to osmotic stress | 3.744353e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.789755e-3 |
GO:0048859 | formation of anatomical boundary | 3.789755e-3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 3.789755e-3 |
GO:0016570 | histone modification | 3.937589e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 4.037415e-3 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 4.037415e-3 |
GO:0015931 | nucleobase-containing compound transport | 4.054763e-3 |
GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 4.436462e-3 |
GO:0006513 | protein monoubiquitination | 4.462426e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 4.466701e-3 |
GO:0060459 | left lung development | 4.470393e-3 |
GO:0040016 | embryonic cleavage | 4.470393e-3 |
GO:0006298 | mismatch repair | 4.703847e-3 |
GO:0016926 | protein desumoylation | 4.759902e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 4.807219e-3 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 4.807219e-3 |
GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation | 4.874351e-3 |
GO:0030210 | heparin biosynthetic process | 4.874351e-3 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 4.910127e-3 |
GO:0000097 | sulfur amino acid biosynthetic process | 4.910127e-3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 4.926007e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 5.021908e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 5.021908e-3 |
GO:0015969 | guanosine tetraphosphate metabolic process | 5.093401e-3 |
GO:0006666 | 3-keto-sphinganine metabolic process | 5.093401e-3 |
GO:0051567 | histone H3-K9 methylation | 5.099396e-3 |
GO:0034421 | post-translational protein acetylation | 5.291656e-3 |
GO:0008063 | Toll signaling pathway | 5.291656e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 5.517563e-3 |
GO:0043457 | regulation of cellular respiration | 5.517563e-3 |
GO:0019438 | aromatic compound biosynthetic process | 5.622166e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 5.691212e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 5.771652e-3 |
GO:0048680 | positive regulation of axon regeneration | 5.851859e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 6.034564e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 6.034564e-3 |
GO:0040038 | polar body extrusion after meiotic divisions | 6.034564e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 6.034564e-3 |
GO:0042941 | D-alanine transport | 6.034564e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 6.075735e-3 |
GO:0000154 | rRNA modification | 6.075735e-3 |
GO:0035305 | negative regulation of dephosphorylation | 6.174879e-3 |
GO:0051340 | regulation of ligase activity | 6.289372e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 6.309559e-3 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 6.398437e-3 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 6.435025e-3 |
GO:0051322 | anaphase | 6.460621e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 6.557827e-3 |
GO:0018394 | peptidyl-lysine acetylation | 6.711400e-3 |
GO:0035630 | bone mineralization involved in bone maturation | 6.748683e-3 |
GO:0051205 | protein insertion into membrane | 6.806825e-3 |
GO:0070508 | cholesterol import | 6.807240e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 6.807240e-3 |
GO:0043094 | cellular metabolic compound salvage | 6.807240e-3 |
GO:0009396 | folic acid-containing compound biosynthetic process | 6.823744e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 6.852513e-3 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 7.180157e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 7.199693e-3 |
GO:0010871 | negative regulation of receptor biosynthetic process | 7.199693e-3 |
GO:0006290 | pyrimidine dimer repair | 7.296986e-3 |
GO:0006304 | DNA modification | 7.418726e-3 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 7.628063e-3 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 7.628063e-3 |
GO:0021570 | rhombomere 4 development | 7.628063e-3 |
GO:0016569 | covalent chromatin modification | 7.663713e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 7.684176e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.793371e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 7.920663e-3 |
GO:0032780 | negative regulation of ATPase activity | 7.973107e-3 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 7.973107e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 7.988940e-3 |
GO:0051983 | regulation of chromosome segregation | 8.033773e-3 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 8.333218e-3 |
GO:0048382 | mesendoderm development | 8.333946e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 8.333946e-3 |
GO:0002352 | B cell negative selection | 8.333946e-3 |
GO:0009059 | macromolecule biosynthetic process | 8.486200e-3 |
GO:0050685 | positive regulation of mRNA processing | 8.769294e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 8.912412e-3 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 8.938344e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 8.938344e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 8.938344e-3 |
GO:0019307 | mannose biosynthetic process | 8.938344e-3 |
GO:0000722 | telomere maintenance via recombination | 8.938344e-3 |
GO:0048793 | pronephros development | 9.060077e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 9.153390e-3 |
GO:2000256 | positive regulation of male germ cell proliferation | 9.235770e-3 |
GO:0042840 | D-glucuronate catabolic process | 9.235770e-3 |
GO:0042231 | interleukin-13 biosynthetic process | 9.235770e-3 |
GO:0035470 | positive regulation of vascular wound healing | 9.235770e-3 |
GO:0009066 | aspartate family amino acid metabolic process | 9.410593e-3 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 9.507812e-3 |
GO:0070997 | neuron death | 9.669009e-3 |
GO:0000910 | cytokinesis | 9.701324e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 9.736636e-3 |
GO:0048015 | phosphatidylinositol-mediated signaling | 9.803291e-3 |
GO:0001831 | trophectodermal cellular morphogenesis | 9.845930e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 9.950122e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 9.950122e-3 |
GO:0048733 | sebaceous gland development | 9.950122e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 9.950122e-3 |
GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 9.950122e-3 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 9.950122e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.001828e-2 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.020066e-2 |
GO:0007080 | mitotic metaphase plate congression | 1.053300e-2 |
GO:0051313 | attachment of spindle microtubules to chromosome | 1.060734e-2 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 1.062454e-2 |
GO:0061360 | optic chiasma development | 1.062454e-2 |
GO:2000597 | positive regulation of optic nerve formation | 1.062454e-2 |
GO:0035799 | ureter maturation | 1.062454e-2 |
GO:0006788 | heme oxidation | 1.062454e-2 |
GO:0006481 | C-terminal protein methylation | 1.062454e-2 |
GO:0035562 | negative regulation of chromatin binding | 1.062454e-2 |
GO:0021633 | optic nerve structural organization | 1.062454e-2 |
GO:0021650 | vestibulocochlear nerve formation | 1.062454e-2 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 1.065238e-2 |
GO:0042256 | mature ribosome assembly | 1.065238e-2 |
GO:0006172 | ADP biosynthetic process | 1.065238e-2 |
GO:0007228 | positive regulation of hh target transcription factor activity | 1.065238e-2 |
GO:0031047 | gene silencing by RNA | 1.070569e-2 |
GO:0030901 | midbrain development | 1.079039e-2 |
GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 1.099511e-2 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 1.105479e-2 |
GO:0051238 | sequestering of metal ion | 1.105479e-2 |
GO:0006446 | regulation of translational initiation | 1.156078e-2 |
GO:0033083 | regulation of immature T cell proliferation | 1.179829e-2 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 1.198845e-2 |
GO:0030833 | regulation of actin filament polymerization | 1.201326e-2 |
GO:0043486 | histone exchange | 1.213949e-2 |
GO:0007034 | vacuolar transport | 1.216239e-2 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 1.227440e-2 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.227440e-2 |
GO:0050684 | regulation of mRNA processing | 1.240479e-2 |
GO:0010823 | negative regulation of mitochondrion organization | 1.244305e-2 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 1.255232e-2 |